A method of treating an individual to increase the individual's bone mineral density (BMD) is disclosed. The method includes co-administering a calcitonin-like agent and a DHEA-like agent. Also disclosed are methods for potentiating the effect of treatment with a calcitonin-like agent on BMD and for increasing BMD in an individual being treated with DHEA, e.g., for treatment of systemic lupus erythematosus (SLE).

 
Web www.patentalert.com

< Polynucleotides encoding soluble zalpha11 cytokine receptors

> Method for selecting allosteric regulators of class III G protein-coupled receptors

> Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response

~ 00558